Combustion Derived Air Pollution and Vascular Function

NCT ID: NCT00775099

Last Updated: 2008-10-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-09-30

Study Completion Date

2006-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Air pollution is a major cause of cardiovascular morbidity and mortality. The components of air pollution responsible and the mechanisms through which they might mediate these harmful effects remain only partially understood. The link between cardiovascular disease and air pollution is strongest for fine particulate matter. Fine particulate matter (PM) is produced from the combustion of fossil fuels with the most significant threat thought to be posed by small particles less than 10µm (PM 10) which can be inhaled into the lungs. We propose to identify the precise component of diesel exhaust that mediates the adverse cardiovascular effects using a carbon particle generator, and a particle concentrator. The aim of this study proposal is to assess the vascular effects of different types and components of air pollution in healthy subjects. We intend to test the hypotheses that:

1. Combustion derived nanoparticulate causes an acute impairment of endothelial vasomotor and fibrinolytic function in healthy volunteers.
2. Exposure to combustion derived air pollution is associated with increased thrombus formation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Endothelial Dysfunction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Air Pollution Particles Particulate Matter Vascular function Endothelial function Thrombosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Filtered Air Exposure

1 hour exposure to filtered air during intermittent exercise

Group Type EXPERIMENTAL

Forearm Vascular Study

Intervention Type PROCEDURE

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Badimon Chamber

Intervention Type PROCEDURE

Ex-vivo assessment of thrombus formation using Badimon Chamber

Diesel Exhaust Exposure

1 hour exposure to dilute diesel exhaust at a concentration of 300 µg/m3 during intermittent exercise

Group Type EXPERIMENTAL

Forearm Vascular Study

Intervention Type PROCEDURE

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Badimon Chamber

Intervention Type PROCEDURE

Ex-vivo assessment of thrombus formation using Badimon Chamber

Filtered Diesel Exposure

1 hour exposure to diesel exhaust with all particulates filtered out using teflon filter with intermittent exercise

Group Type EXPERIMENTAL

Forearm Vascular Study

Intervention Type PROCEDURE

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Badimon Chamber

Intervention Type PROCEDURE

Ex-vivo assessment of thrombus formation using Badimon Chamber

PALAS Exposure

1 hour exposure to pure carbon particles produced by PALAS generator during intermittent exercise

Group Type EXPERIMENTAL

Forearm Vascular Study

Intervention Type PROCEDURE

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Badimon Chamber

Intervention Type PROCEDURE

Ex-vivo assessment of thrombus formation using Badimon Chamber

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Forearm Vascular Study

Forearm venous occlusion plethysmography to measure forearm blood flow during intra-arterial infusion of the vasodilators Verapamil (10-100 µg/min), bradykinin (100-1000 pmol/min), sodium nitroprusside (2-8 µg/min) and Acetylcholine (5-20 mg/min).

Intervention Type PROCEDURE

Badimon Chamber

Ex-vivo assessment of thrombus formation using Badimon Chamber

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

BK SNP ACh

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy volunteers

Exclusion Criteria

* Current smokers
* Significant occupational exposure to air pollution
* History of lung disease
* Women of child-bearing potential
* Malignant arrhythmias
* Renal or hepatic failure
* Significant co-morbidity
* Systolic blood pressure \>190 or \<100 mmHg
* Previous history of blood dyscrasia
* Unable to tolerate the supine position
* Lack of informed consent
* Blood donation within last 3 months
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute for Public Health and the Environment (RIVM)

OTHER_GOV

Sponsor Role collaborator

University of Edinburgh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University of Edinburgh

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nicholas L Mills, MB BCh MRCP

Role: PRINCIPAL_INVESTIGATOR

University of Edinburgh

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Edinburgh

Edinburgh, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005 Dec 20;112(25):3930-6. doi: 10.1161/CIRCULATIONAHA.105.588962.

Reference Type BACKGROUND
PMID: 16365212 (View on PubMed)

Langrish JP, Watts SJ, Hunter AJ, Shah AS, Bosson JA, Unosson J, Barath S, Lundback M, Cassee FR, Donaldson K, Sandstrom T, Blomberg A, Newby DE, Mills NL. Controlled exposures to air pollutants and risk of cardiac arrhythmia. Environ Health Perspect. 2014 Jul;122(7):747-53. doi: 10.1289/ehp.1307337. Epub 2014 Mar 25.

Reference Type DERIVED
PMID: 24667535 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05/S1103/46

Identifier Type: -

Identifier Source: org_study_id